These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9489092)

  • 21. [Consensus diagnosis and treatment of arterial intermittent claudication. Central Guidance Organization for Peer Review].
    Kitslaar PJ
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2396-400. PubMed ID: 9554160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Management of patients with intermittent claudication].
    Fiessinger JN; Sapoval M; Julia P
    Rev Prat; 2005 Jun; 55(11):1190-2, 1195-7. PubMed ID: 16164064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    ; Leizorovicz A; Becker F
    Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
    Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral arterial disease. Are your legs at risk?
    Mayo Clin Health Lett; 2004 Mar; 22(3):1-3. PubMed ID: 15000063
    [No Abstract]   [Full Text] [Related]  

  • 26. Peripheral vascular disease: diagnosis and treatment.
    Sontheimer DL
    Am Fam Physician; 2006 Jun; 73(11):1971-6. PubMed ID: 16770929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM; Mendelsohn F; Henry TD; Hermiller JB; Litt M; Saucedo JF; Weiss RJ; Kandzari DE; Kleiman N; Anderson RD; Gottlieb D; Karlsberg R; Snell J; Rocha-Singh K
    Am Heart J; 2007 May; 153(5):874-80. PubMed ID: 17452167
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Walking exercise in patients with intermittent claudication. Experience in routine clinical practice.
    Bartelink ML; Stoffers HE; Biesheuvel CJ; Hoes AW
    Br J Gen Pract; 2004 Mar; 54(500):196-200. PubMed ID: 15006125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombotic drugs in the primary medical management of intermittent claudication: a meta-analysis.
    Girolami B; Bernardi E; Prins MH; ten Cate JW; Prandoni P; Hettiarachchi R; Marras E; Stefani PM; Girolami A; Büller HR
    Thromb Haemost; 1999 May; 81(5):715-22. PubMed ID: 10365743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefits of low-intensity pain-free treadmill exercise on functional capacity of individuals presenting with intermittent claudication due to peripheral arterial disease.
    Barak S; Stopka CB; Archer Martinez C; Carmeli E
    Angiology; 2009; 60(4):477-86. PubMed ID: 18818240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of exercise training in peripheral arterial disease.
    Milani RV; Lavie CJ
    Vasc Med; 2007 Nov; 12(4):351-8. PubMed ID: 18048473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intermittent claudication. Synthesis and conclusions].
    Van der Stricht J
    Phlebologie; 1978; 31(4):425-30. PubMed ID: 740730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease.
    Hodges LD; Sandercock GR; Das SK; Brodie DA
    Clin Physiol Funct Imaging; 2008 Jan; 28(1):32-7. PubMed ID: 18005078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effects of 1-year optimal medical treatment with and without additional PTA on inflammatory markers of atherosclerosis in patients with PAD. Results from the Oslo Balloon Angioplasty versus Conservative Treatment (OBACT) study.
    Nylaende M; Kroese AJ; Morken B; Stranden E; Sandbaek G; Lindahl AK; Arnesen H; Seljeflot I
    Vasc Med; 2007 Nov; 12(4):275-83. PubMed ID: 18048463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events.
    Coppola G; Novo S
    Arch Med Res; 2007 Jul; 38(5):479-88. PubMed ID: 17560452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermittent claudication. Conservative treatment, endovascular repair or open surgery for femoropopliteal disease.
    Jensen LP
    Ann Chir Gynaecol; 1998; 87(2):137-40. PubMed ID: 9676323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Electrotherapy of intermittent claudication].
    Kopasz E
    Orv Hetil; 1974 Apr; 115(17):990-1. PubMed ID: 4545283
    [No Abstract]   [Full Text] [Related]  

  • 38. [The principles of care for patients with intermittent claudication].
    Roztocil K
    Vnitr Lek; 2010 Jul; 56(7):724-6. PubMed ID: 20842920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. "Risk factors" and manifestations of arteriosclerosis in patients with intermittent claudication compared to normal persons.
    Jacobsen UK; Dige-Pedersen H; Gyntelberg F; Svendsen UG
    Dan Med Bull; 1984 Apr; 31(2):145-8. PubMed ID: 6723377
    [No Abstract]   [Full Text] [Related]  

  • 40. Vascular claudication: how to individualize treatment.
    Gray BH; Sullivan TM
    Cleve Clin J Med; 1997 Sep; 64(8):429-36. PubMed ID: 9308219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.